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Summary 
The case of a 25year-old patient is reported who suffered from a syndrome similar to immune 
complex disease following cholera revaccination. The clinical picture included fever, muscle, joint 
and abdominal pain, vomiting, serositis, hepatitis, suspected myocarditis, anaemia nd thrombocy- 
topenia. Clinical symptoms ubsided spontaneously within two weeks. This case illustrates a hazard of 
cholera vaccination so far not reported in the literature. 
Introduction 
Cholera vaccination in its present form provides 
onlv limited orotection for the individual and has 
proved ineffective in preventing the introduction of 
cholera into a country and spread of the disease 
(WHO, 1983). WHO has, therefore, eliminated it 
from International Health Regulations (WHO, 1973). 
However, a certificate of vaccination is still required 
by many countries for travellers arriving from in- 
fected areas, and it is compulsory for all travellers to 
Mozambique (WHO, 1983) in spite of recognized side 
effects. We present a case of adverse reaction to 
cholera vaccine with a syndrome resembling immune 
complex disease, which has so far not been reported in 
connection with cholera vaccination. 
Case report 
A 25year-old Tibetan refugee, living for the last 
two years in Switzerland, requested cholera vaccina- 
tion because she had to travel to India. 18 months and 
one year before she had been operated on for 
echinococcal cyst (Echinococcus granulosus) in the left 
lower lung and a recurrent cyst in the thoracic wall. 
Subsequently, she received chemotherapy with 
mebendazole for three months. Serum antibody titres 
diminished but remained slightly elevated. At the 
time of vaccination, she was in good general condi- 
tion. A first dose of 1.0 ml of anti-cholera vaccine 
(Berna, 8000 mill. V. cholerae Inaba, Ogawa, El Tor) 
was given together with oral polio vaccine without 
side effects. Three weeks later she received a second 
dose of 1.0 ml of the same anti-cholera vaccine alone. 
Two hours later the patient developed fever (38.5”(Z), 
intensive frontal and occipital headache, photopho- 
bia, vomiting and pain in the lower abdomen. She was 
admitted to-hospital one week later. 
Clinical examination showed imnaired well-beina. 
normal consciousness, slight neck- stiffness, diffuse 
muscle and joint pain, localized pain in the right 
upper abdomen, and a 2/6 cardiac ejection murmur. 
Temperature was 39.2”C, pulse rate lOO/min, blood 
pressure 95/70 mmHg. Physical examination was 
otherwise normal. 
Investigations showed: erythrocyte sedimentation 
rate 50/95 mm. haemoelobin 12.1 ddl. white cell 
count 8.6 x lo’/1 with zO% neutrophils,‘69% bands, 
0.5% eosinophils, 7.5% lymphocytes, 2.5% mono- 
cytes, 82,000 platelets; slight elevation of blood urea 
and creatinine, moderate elevation of transaminases; 
bilirubin and alkaline phosphatase within normal 
range; HBs antigen negative, HBs and HA antibodies 
positive. CSF: 53 x lo6 cells (53% polymorphonuc- 
lear, 47% mononuclear), protein 510 mgil. All bacter- 
iological and viral tests were negative. The ECG 
showed signs of lateral and diaphragmatic ischaemia 
and incomplete RBBB. Chest X-rav was normal. 
Laparoscopy revealed a small amount of somewhat 
cloudv. vellowish ascites. CT scans of the abdomen 
and skull were normal, in particular without signs of 
cystic structures. 
Headache, neck stiffness, pain, vomiting and fever 
disappeared without specific treatment within five 
days. Renal parameters and CSF became normal, 
transaminases returned partially to normal and ESR 
remained unchanged. Haemoglobin dropped to 
10.5 g/l within three days and remained at this level. 
No haemolysis and no blood loss could be demons- 
trated. WBC became normal within one week and 
platelets rose gradually to 629,000. Repolarization in 
the ECG improved, but RBBB persisted. The patient 
was discharged on the 11th day in good condition. 
Discussion 
Mild side effects after cholera vaccination are 
frequent. Marked side effects involving the central 
nervous system have been reported (VIPARELLI et al., 
1974), although mainly as sporadic cases (SCOLERI et 
al., 1974; GRANATA et al., 1974; GENTILE & CARUSO, 
1974; COLUCCI D’AMATO & FEIS, 1974; SCHRADER, 
1975). Single case reports mention side effects involv- 
ing the cardiovascular system (KOUTSAIMINIS & RBE, 
1978), the kidneys (EISINGER & SMITH, 1979) and the 
skin (COTTERILL & SHAPIRO, 1978). The clinical 
picture in the case reported here may represent 
nnmune complex disease. However, this hypothesis is 
based exclusivelv on the sirnilaritv of the clinical 
syndrome, but has not been proved by any specific 
tests. 
Cholera vaccine is a potent stimulant of the immune 
system and it has been suggested by GENTILE & 
CARUSO (1974) that it acts like Freund’s adjuvant. 
Possibly, the immune response in this patient was 
modified by the past history of echinococcosis. 
The possibility of serious complications might be a 
reason for further restriction of the use of this vaccine. 
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